Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rebekka Lund Hansen"'
Autor:
Lene Dreyer, Lars Erik Kristensen, Mark Andrew Ainsworth, Tanja Schjødt Jørgensen, Simon Francis Thomsen, Katrine Risager Christensen, Marie Skougaard, Zara R Stisen, Rebekka Lund Hansen, Mette Mogensen
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objectives Exploring patients’ perspectives for significant factors of relevance in living with a chronic disease is important to discover unmet needs and challenges. The primary objective of this study was to explore disease-related and treatment-
Externí odkaz:
https://doaj.org/article/877f7b18b4904b2ea1793f09a05ad214
Autor:
Lene Dreyer, Tanja Schjødt Jørgensen, Philip J. Mease, Vibeke Strand, Christine Ballegaard, Marie Skougaard, Rebekka Lund Hansen, Lars Erik Kristensen
Publikováno v:
Jørgensen, T S, Skougaard, M, Hansen, R L, Ballegaard, C, Mease, P, Strand, V, Dreyer, L & Kristensen, L E 2021, ' Relation between fatigue and ACR response in patients with psoriatic arthritis treated with tumor necrosis factor inhibitor therapy : a population-based cohort study ', Journal of Rheumatology, vol. 48, no. 6, 191107, pp. 829-835 . https://doi.org/10.3899/jrheum.191107
Jørgensen, T S, Skougaard, M, Hansen, R L, Ballegaard, C, Mease, P, Strand, V, Dreyer, L & Kristensen, L E 2021, ' Relation between fatigue and ACR response in patients with psoriatic arthritis treated with tumor necrosis factor inhibitor therapy : A population-based cohort study ', Journal of Rheumatology, vol. 48, no. 6, pp. 829-835 . https://doi.org/10.3899/jrheum.191107
Jørgensen, T S, Skougaard, M, Hansen, R L, Ballegaard, C, Mease, P, Strand, V, Dreyer, L & Kristensen, L E 2021, ' Relation between fatigue and ACR response in patients with psoriatic arthritis treated with tumor necrosis factor inhibitor therapy : A population-based cohort study ', Journal of Rheumatology, vol. 48, no. 6, pp. 829-835 . https://doi.org/10.3899/jrheum.191107
OBJECTIVE: The objective of this population-based cohort study was to investigate the association of fatigue with disease activity and drug survival in PsA patients receiving their first tumor necrosis factor inhibitor (TNFi). METHODS: Data on patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86642c929712611ca64c4c7e2f7bc3f8
https://vbn.aau.dk/da/publications/740ad738-5b78-4de1-81bb-50d91e54a5ef
https://vbn.aau.dk/da/publications/740ad738-5b78-4de1-81bb-50d91e54a5ef
Autor:
Tanja Schjødt Jørgensen, Lennart T H Jacobsson, Ulf Lindström, Dan Nordström, Johan Askling, Anna-Mari Hokkanen, Johan K. Wallman, Sella Aarrestad Provan, Brigitte Michelsen, Kalle Aaltonen, Arni Jon Geirsson, Bente Glintborg, Merete Lund Hetland, Artis Danbio (Denmark), Rebekka Lund Hansen, Lars Erik Kristensen, Srq registries, Kathrine Lederballe Grøn, Niels Steen Krogh, Daniela Di Giuseppe, Bjorn Gudbjornsson
Publikováno v:
Danish Rheumatology Database (DANBIO), Anti-RheumaticTherapy in Sweden/Swedish Rheumatology Quality (ARTIS/SRQ), Center for Rheumatology Research (ICEBIO), Finnish Register of Biological Treatment (ROB-FIN) & Norwegian Antirheumatic Drug Register (NOR-DMARD) 2022, ' One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis : Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses ', Arthritis Care and Research, vol. 74, no. 5, pp. 748-758 . https://doi.org/10.1002/acr.24523
Objective: To describe baseline characteristics and to compare treatment effectiveness of secukinumab versus tumor necrosis factor inhibitors (TNFi) in patients with spondyloarthritis (SpA) using adalimumab as the main comparator. Methods: This was a
Autor:
Thorvadur J Love, Lene Dreyer, Sella Aarrestad Provan, Johan K. Wallman, Merete Lund Hetland, Rebekka Lund Hansen, Bente Glintborg, L.E. Kristensen, Tore K Kvien, Kalle Aaltonen, Dan Nordström, Tanja Schoedt Jørgensen, Lennart T H Jacobsson, Bjorn Gudbjornsson, Eirik Kristianslund, Johan Askling, Daniela Di Giuseppe
Publikováno v:
Lund Hansen, R, Schoedt Jørgensen, T, Dreyer, L, Hetland, M L, Glintborg, B, Askling, J, Di Giuseppe, D, Jacobsson, L T H, Wallman, J K, Nordstrom, D, Aaltonen, K, Kristianslund, E K, Kvien, T K, Provan, S A, Gudbjornsson, B, Love, T J & Kristensen, L E 2021, ' Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics : a Nordic population-based cohort study ', Rheumatology, vol. 60, no. 1, keaa237, pp. 140–146 . https://doi.org/10.1093/rheumatology/keaa237
Objectives To assess secular trends in baseline characteristics of PsA patients initiating their first or subsequent biologic DMARD (bDMARD) therapy and to explore prescription patterns and treatment rates of bDMARDs from 2006 to 2017 in the Nordic c
Autor:
Rebekka Lund Hansen, M.L. Hetland, S. Aarrestad Provan, Ulf Lindström, Bjorn Gudbjornsson, Anna-Mari Hokkanen, N. Steen Krogh, Brigitte Michelsen, L.E. Kristensen, D. Di Giuseppe, Johan K. Wallman, B. Glintborg, L. T. H. Jacobsson, Kalle Aaltonen, Arni Jon Geirsson, T. Schjødt Jørgensen, Kathrine Lederballe Grøn, Johan Askling
Publikováno v:
Annals of the Rheumatic Diseases. 79:724-725
Background:Tumor necrosis factor inhibitors (TNFi) have been available for more than a decade for treatment of spondyloarthrtitis (SpA). Secukinumab (SEC) represents a new mode of action, but few studies have compared outcomes in patients(pts) treate
Autor:
Bjorn Gudbjornsson, Tore K Kvien, Lars Erik Kristensen, Lene Dreyer, Lennart T. H. Jacobsson, Johan K. Wallman, Rebekka Lund Hansen, Eirik Kristianslund, Bente Glintborg, Dan Nordström, Johan Askling, Thorvardur Jon Love, Tanja Schjødt Jørgensen, Daniela Di Giuseppe, Sella Aarrestad Provan, Merete Lund Hetland, Kalle Aaltonen
Publikováno v:
Saturday, 15 June 2019.
Background Psoriatic arthritis (PsA) is a chronic inflammatory disorder associated with skin and joint manifestations, several extra-articular symptoms, various comorbidities, and disability[1,2]. The emergence of tumour necrosis factor inhibitor (TN
Autor:
T. Schjødt Jørgensen, Rebekka Lund Hansen, Joseph F. Merola, L.E. Kristensen, L. M. Perez-Chada, Marie Skougaard, Zara R Stisen, P. Benzin, Mette Mogensen
Publikováno v:
Annals of the Rheumatic Diseases. 80:1312.1-1312
Background:Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory disease. It has a heterogeneous clinical presentation with main features being joint swelling and pain, skin and nail psoriasis, enthesitis, and dactylitis. Self-reported
Autor:
T. Schjødt Jørgensen, Bart P H Pouls, Rebekka Lund Hansen, L.E. Kristensen, Christopher Sjöwall, B. van den Bemt
Publikováno v:
Annals of the Rheumatic Diseases. 79:1459.1-1459
Background:Anti-tumour necrosis factor (anti-TNF) adherence is suboptimal and impacted by multiple psychological, practical and physical barriers, such as patient needle phobia, lack of confidence in self-administration skills and forgetting injectio